Company Analysis Shandong Weigao Group Medical Polymer Company Limited
1. Summary
Advantages
- Price (4.66 HK$) is less than fair price (6.28 HK$)
- Dividends (3.5%) are higher than the sector average (2.42%).
- Current debt level 13.34% is below 100% and has decreased over 5 years from 22.25%.
- The company's current efficiency (ROE=9.06%) is higher than the sector average (ROE=5.19%)
Disadvantages
- The stock's return over the last year (-38.36%) is lower than the sector average (-21.45%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
Shandong Weigao Group Medical Polymer Company Limited | Healthcare | Index | |
---|---|---|---|
7 days | -2.9% | -0.3% | 1% |
90 days | 15.6% | 13.6% | 8% |
1 year | -38.4% | -21.5% | 11.9% |
1066 vs Sector: Shandong Weigao Group Medical Polymer Company Limited has significantly underperformed the "Healthcare" sector by -16.91% over the past year.
1066 vs Market: Shandong Weigao Group Medical Polymer Company Limited has significantly underperformed the market by -50.28% over the past year.
Stable price: 1066 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 1066 with weekly volatility of -0.7377% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (4.66 HK$) is lower than the fair price (6.28 HK$).
Price significantly below the fair price: The current price (4.66 HK$) is 34.8% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (15.64) is lower than that of the sector as a whole (35.42).
P/E vs Market: The company's P/E (15.64) is lower than that of the market as a whole (26.77).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.31) is lower than that of the sector as a whole (3.68).
P/BV vs Market: The company's P/BV (1.31) is higher than that of the market as a whole (-11.93).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.37) is lower than that of the sector as a whole (7.59).
P/S vs Market: The company's P/S indicator (2.37) is lower than that of the market as a whole (2.78).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (8.13) is higher than that of the sector as a whole (2.91).
EV/Ebitda vs Market: The company's EV/Ebitda (8.13) is lower than that of the market as a whole (9.94).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 1.7% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (1.7%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1.51%).
5.4. ROE
ROE vs Sector: The company's ROE (9.06%) is higher than that of the sector as a whole (5.19%).
ROE vs Market: The company's ROE (9.06%) is higher than that of the market as a whole (6.28%).
5.5. ROA
ROA vs Sector: The company's ROA (5.97%) is higher than that of the sector as a whole (3.47%).
ROA vs Market: The company's ROA (5.97%) is higher than that of the market as a whole (3.38%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 3.5% is higher than the average for the sector '2.42%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 3.5% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 3.5% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (36.6%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription